Results 91 to 100 of about 909,797 (181)

Risk of Donor‐Derived Infections From Organ Donors Colonized or Infected With Multidrug‐Resistant Gram‐Negative Bacteria: A Systematic Review and Meta‐Analysis

open access: yesClinical Transplantation, Volume 40, Issue 10, October 2026.
ABSTRACT Background The presence of multidrug‐resistant Gram‐negative (MDR‐GN) organisms in solid organ transplantation (SOT) donors raises concerns regarding transplant safety. Methods We searched PubMed and Scopus (2010–2025) for observational studies reporting donor‐derived infections (DDI) among SOT recipients from donors with MDR‐GN colonization ...
Themistoklis Paraskevas   +10 more
wiley   +1 more source

Antibacterial activity of eravacycline against Klebsiella pneumoniae isolates: an in vitro study

open access: yesMicrobiology Spectrum
Eravacycline, a novel tetracycline antibiotic, may be an effective treatment option for Klebsiella pneumoniae infections. We thus conducted an in vitro susceptibility analysis for eravacycline in 211 K. pneumoniae isolates.
Yuanzhi Gong   +7 more
doaj   +1 more source

Successful Treatment of Klebsiella pneumoniae Harboring a Klebsiella pneumoniae Carbapenemase Isolated from Lumbar Wound Infection and Blood in a Patient with Hardware Retention

open access: yesCase Reports in Infectious Diseases, 2017
Infections caused by carbapenem-resistant Enterobacteriaceae, especially carbapenemase producing Klebsiella pneumoniae, represent an urgent threat as outlined by the Centers for Disease Control and Prevention (CDC).
Alan Bulbin   +4 more
doaj   +1 more source

Network Integrative Genomic and Transcriptomic Analysis of Carbapenem-Resistant Klebsiella pneumoniae Strains Identifies Genes for Antibiotic Resistance and Virulence

open access: yesmSystems, 2019
Global increases in the use of carbapenems have resulted in several strains of Gram-negative bacteria acquiring carbapenem resistance, thereby limiting treatment options. Klebsiella pneumoniae is a common carbapenem-resistant pathogenic bacterium that is
Muyoung Lee   +6 more
doaj   +1 more source

Risk Factors of Blood Culture Positivity and Mortality in Bloodstream Infections: A Population‐Based Study of Patients With B‐Cell Malignancies

open access: yesEuropean Journal of Haematology, Volume 117, Issue 4, Page 1061-1071, October 2026.
ABSTRACT Background Bloodstream infections remain a major cause of mortality among cancer patients. Pathogen surveillance and risk stratification tools are key to improved management. This study describes trends in causative pathogens and explores risk factors for positive blood cultures (PBCs) and post‐infection mortality in cancer patients.
Mathias Holmsgaard Eskesen   +7 more
wiley   +1 more source

Poor Glycemic Control in Carbapenem-Resistant Klebsiella pneumoniae Infections: Impact on Epidemiological Features, Mortality Risks, and Polymyxin Resistance [PDF]

open access: yes
Qiuyan Wang,1 Tao Yan,1 Chengcheng Ma,1 Xuan Teng,1 Chengyin Shen,2 Na Wang,3 Kexue Yu,1 Wenwen Chu,1 Qiang Zhou,1 Zhou Liu1,4 1Department of Clinical Laboratory, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, People’s Republic
Wang N   +9 more
core  

Effect of combination therapy containing a high dose carbapenem on mortality in patients with carbapenem-resistant klebsiella pneumoniae bloodstream infection [PDF]

open access: yes, 2018
To evaluate the impact of high-dose (HD) carbapenem-based combination therapy on clinical outcome in patients with monomicrobial carbapenem-resistant Klebsiella pneumoniae (CR-KP) bloodstream-infection (BSI)
Viscoli, Claudio   +45 more
core   +1 more source

Using Synthetic Glycans to Investigate Anti‐Glycan Antibodies and Explore Their Medical Potential

open access: yesAngewandte Chemie International Edition, Volume 65, Issue 39, 21 September 2026.
Anti‐glycan antibodies are essential in health and disease. Access to novel glycan structures paves the way for progress in antibody profiling for biomarker discovery, antibody development, and vaccine design. We summarize the strategies to synthesize and utilize synthetic glycans for the development and application of anti‐glycan antibodies in basic ...
Fabienne Weber   +4 more
wiley   +1 more source

Prevalence of Carbapenem resistant Klebsiella pneumoniae infections in a Nigerian Teaching Hospital

open access: yes, 2021
Background: The emergence of carbapenem resistant Klebsiella pneumoniae (CRKP) is of great concern because of the limited options for treatment. While carbapenem resistant Klebsiella pneumoniae is increasingly identified worldwide, limited data is ...
Ogunsola, F.T., Oshun, P.O.
core  

Clinical and Microbiological Characteristics of Carbapenem-Resistant Klebsiella pneumoniae Associated Recurrent Urinary Tract Infections [PDF]

open access: yes
Huijun Cao,1,2,* Hang Cheng,3,* Jing Zhou,3 Jiyuan Zhao,3 Mei Xu,1 Ying Fei1 1Center for Clinical Laboratories, the Affiliated Hospital of Guizhou Medical University, Guiyang, People’s Republic of China; 2College of Life Sciences, Fujian Normal ...
Xu M   +5 more
core  

Home - About - Disclaimer - Privacy